Showing results (41-50 of 52) with videos related to
Sort By:
Pageof 6
Nature Communications|October 13, 2019
Inference of transcription factor binding from cell-free DNA enables tumor subtype prediction and early detectionPeter Ulz, Samantha Perakis, Qing Zhou, et al.Journal of Hematology & Oncology|April 17, 2016
Azacitidine front-line in 339 patients with myelodysplastic syndromes and acute myeloid leukaemia: comparison of French-American-British and World Health Organization classificationsLisa Pleyer, Sonja Burgstaller, Reinhard Stauder, et al.Cancers|May 28, 2022
Adverse Events in 1406 Patients Receiving 13,780 Cycles of Azacitidine within the Austrian Registry of Hypomethylating Agents-A Prospective Cohort Study of the AGMT Study-GroupMichael Leisch, Michael Pfeilstöcker, Reinhard Stauder, et al.Nature Communications|October 14, 2014
Germline variants in the SEMA4A gene predispose to familial colorectal cancer type XEduard Schulz, Petra Klampfl, Stefanie Holzapfel, et al.American Journal of Hematology|August 7, 2023
Cox proportional hazards deep neural network identifies peripheral blood complete remission to be at least equivalent to morphologic complete remission in predicting outcomes of patients treated with azacitidine-A prospective cohort study by the AGMTLisa Pleyer, Marc Vaisband, Manuel Drost, et al.European Journal of Haematology|May 17, 2021
Impact of age on the cumulative risk of transformation in patients with chronic myelomonocytic leukaemiaSigrid Machherndl-Spandl, Eva Jäger, Agnes Barna, et al.International Journal of Molecular Sciences|February 18, 2017
Azacitidine for Front-Line Therapy of Patients with AML: Reproducible Efficacy Established by Direct Comparison of International Phase 3 Trial Data with Registry Data from the Austrian Azacitidine Registry of the AGMT Study GroupLisa Pleyer, Hartmut Döhner, Hervé Dombret, et al.Leukemia & Lymphoma|January 5, 2021
Decitabine treatment in 311 patients with acute myeloid leukemia: outcome and impact of TP53 mutations - a registry based analysisJan M Middeke, Raphael Teipel, Christoph Röllig, et al.International Journal of Molecular Sciences|April 30, 2020
Correlation of RAS-Pathway Mutations and Spontaneous Myeloid Colony Growth with Progression and Transformation in Chronic Myelomonocytic Leukemia-A Retrospective Analysis in 337 PatientsKlaus Geissler, Eva Jäger, Agnes Barna, et al.Science Translational Medicine|November 26, 2025
Lymphotoxin alpha eradicates acute myeloid leukemia and simultaneously promotes healthy hematopoiesis in miceUlrike Höckendorf, Sayantanee Dutta, Arnold Kloos, et al.Pageof 6